Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Is The Projected Market Size Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market By 2029?
The minimal access surgery market for glaucoma has seen substantial, rapid expansion lately, with projections indicating a rise from a valuation of $0.7 billion in 2024 to $0.89 billion by 2025, reflecting an impressive compound annual growth rate of 27.6%. This upward trajectory observed over the historical period stems from several contributing factors, including heightened recognition regarding avoiding vision loss, greater capital allocation toward health system facilities, growing patient understanding of sophisticated sight correction procedures, rising knowledge about cutting-edge visual correction modalities, and the implementation of supportive governmental programs.
Projections indicate that the market for minimally invasive glaucoma surgery (MIGS) devices is set for substantial, rapid expansion in the coming years, reaching a valuation of $2.29 billion by 2029 with a compound annual growth rate (CAGR) clocked at 26.5%. This upward trajectory through the projection timeframe is largely fueled by several factors, including the escalating incidence of ocular conditions such as glaucoma, an aging global demographic, enhancements in medical infrastructure, and a persistent demand for therapeutic methods that are both safer and yield better outcomes. Key developments shaping this market throughout this phase involve increased integration of MIGS technologies, technological breakthroughs, the creation of novel minimally invasive surgical tools for glaucoma, the engineering of sophisticated implantable apparatuses, and general progress in the field of ophthalmology.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp
What Are The Main Drivers Boosting The Minimally Invasive Glaucoma Surgery (MIGS) Devices Industry’s Expansion?
The rising incidence of various visual impairments is forecast to act as a catalyst for expanding the market for minimally invasive glaucoma surgery (MIGS) devices in the near future. These eye conditions represent a broad spectrum of ailments impacting ocular health and sight capabilities, their growing frequency being attributable to shifts in daily habits, external surroundings, and the aging demographic trend. MIGS implements represent novel instruments employed in addressing several ophthalmic ailments, chiefly aiming at lowering the pressure inside the eye (IOP) to either halt or manage the advancement of glaucoma; for illustration, projections from the US governmental organization, the National Eye Institute, suggest approximately 2.2 million individuals in the United States will experience some degree of vision impairment by the year 2030, starting from 2024. Consequently, the heightened frequency of eye disorders directly fuels the expansion of the market centered around MIGS apparatus.
What Are The Segment Types Shaping The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
The minimally invasive glaucoma surgery (migs) devicesmarket covered in this report is segmented –
1) By Product: Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Other Products
2) By Surgery: Glaucoma In Conjunction With Cataract, Stand Alone Glaucoma
3) By Target: Trabecular Meshwork, Suprachoroidal Space, Other Targets
4) By Distribution Channel: Direct Tender, Retail Sales
5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS), Other End Users
Subsegments:
1) By Valves: Micro Shunt Valves, Non-penetrating Valves
2) By Glaucoma Drainage Implant: Scleral Drainage Implants, Subconjunctival Drainage Implants
3) By Glaucoma Tube Shunts: Ahmed Tube Shunt, Baerveldt Tube Shunt
4) By Stents: Ab-Interno Stents, Ab-Externo Stents
5) By Other Products: Cyclodestructive Devices, Trabecular Bypass Devices
What Are The Latest Industry Trends Transforming The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
Leading firms within the space for minimally invasive glaucoma surgery (MIGS) devices are concentrating their efforts on creating novel offerings, notably stent injectable systems, aiming to satisfy existing gaps in glaucoma care and enhance results for those affected. A stent injectable system represents a specific type of MIGS apparatus that facilitates the deployment and placement of a tiny stent into the body via a technique resembling an injection, frequently utilizing a purpose-built delivery instrument common in minimally invasive procedures for addressing issues like constricted or obstructed vasculature. As an illustration, in August of 2022, Glaukos Corporation, an American specialist in ophthalmic medical technology, secured 510(k) approval from the United States Food and Drug Administration (FDA) for its iStent Infinite Trabecular Micro-Bypass System. This iStent Infinite is distinguished as a new three-stent injectable mechanism engineered to afford consistent, around-the-clock control over intraocular pressure (IOP) for individuals diagnosed with primary open-angle glaucoma (POAG) whose IOP remains unmanaged despite earlier pharmaceutical interventions and surgical treatments.
Who Are The Prominent Global Companies Shaping The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
Major companies operating in the minimally invasive glaucoma surgery (MIGS) devices market are AbbVie Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Bausch & Lomb Incorporated Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Johnson & Johnson Vision Care Inc., Lumenis Ltd., Staar Surgical Company, Glaukos Corporation, Sight Sciences Inc., Ocular Therapeutix Inc., Iridex Corporation, Ellex Medical Lasers Ltd., New World Medical Inc., MicroSurgical Technology Inc., Nova Eye Medical Limited, Asico LLC, Ziemer Ophthalmic Systems AG, Transcend Medical, iSTAR Medical SA, Ivantis Group Inc., Allergan, InnFocus Inc.
Download The Full Report For Exclusive Market Findings:
Which Region Is Projected To Lead The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market During The Forecast Period?
North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15863&type=smp
Browse Through More Reports Similar to the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market 2025, By The Business Research Company
Minimally Invasive Surgery Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/minimally-invasive-surgery-global-market-report
Minimally Invasive Surgical Instruments Global Market Report 2025
Minimally Invasive And Non Invasive Product And Service Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model